Adaptive Biotechnologies Corporation Share Price
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 20/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 24.42 USD | +1.96% |
|
-3.40% | +50.37% |
| Market Cap | 3.9B 3.47B 3.22B 2.91B 5.48B 369B 5.57B 38.58B 15.16B 193B 14.62B 14.32B 616B | P/E 2026 * |
-45x | P/E 2027 * | -146x |
|---|---|---|---|---|---|
| Enterprise Value | 3.72B 3.31B 3.07B 2.78B 5.23B 353B 5.32B 36.86B 14.48B 185B 13.97B 13.68B 589B | EV / Sales 2026 * |
12.7x | EV / Sales 2027 * | 10.2x |
| Free-Float |
97.95% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
Tradegate
| 1HM | Real-time | |
Deutsche Boerse AG
| 1HM | Delayed | |
Börse Stuttgart
| 1HM | Delayed | |
Boerse Muenchen
| 1HM | Real-time |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | +1.96% | ||
| 1 week | -3.40% | ||
| Current month | -15.50% | ||
| 1 month | -14.65% | ||
| 3 months | +11.71% | ||
| 6 months | +67.49% | ||
| Current year | +50.37% |
| 1 week | 23.85 | 25.91 | |
| 1 month | 23.85 | 30.74 | |
| Current year | 12 | 30.74 | |
| 1 year | 12 | 30.74 | |
| 3 years | 2.28 | 30.74 | |
| 5 years | 2.28 | 37.55 | |
| 10 years | 2.28 | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 07/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 07/04/2024 |
Julie Rubinstein
PSD | President | 54 | 31/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 31/01/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 30/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/10/26 | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 13/10/26 | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 08/10/26 | Exercice | Chairperson | 35,643 | 0.0223% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.96% | -3.40% | +36.96% | +492.72% | 3.9B | ||
| +0.79% | -6.16% | +49.32% | +74.50% | 66.34B | ||
| -0.67% | +5.60% | +10.71% | +88.71% | 52.92B | ||
| +0.15% | +4.69% | +7.31% | +73.25% | 54.82B | ||
| +0.74% | +2.75% | +26.31% | +45.29% | 44.09B | ||
| +3.87% | +10.15% | +20.69% | +132.73% | 43.72B | ||
| +7.91% | +4.30% | +263.91% | +602.72% | 42.13B | ||
| -0.40% | +9.85% | +17.04% | +59.17% | 33.96B | ||
| -1.30% | -0.68% | +37.15% | +7.04% | 26.17B | ||
| +0.06% | +4.88% | +35.66% | +25.52% | 23.37B | ||
| Average | +1.31% | +4.13% | +50.51% | +160.16% | 39.14B | |
| Weighted average by Cap. | +1.33% | +4.77% | +50.97% | +131.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293M 261M 242M 219M 412M 27.8B 419M 2.9B 1.14B 14.55B 1.1B 1.08B 46.41B | 359M 320M 296M 269M 505M 34.03B 513M 3.56B 1.4B 17.81B 1.35B 1.32B 56.81B |
| Net income | -85.54M -76.14M -70.57M -63.94M -120M -8.1B -122M -847M -333M -4.24B -321M -314M -13.53B | -26.11M -23.24M -21.54M -19.52M -36.69M -2.47B -37.3M -258M -102M -1.29B -97.95M -95.92M -4.13B |
| Net Debt | -173M -154M -143M -129M -243M -16.4B -247M -1.71B -673M -8.58B -649M -636M -27.38B | -217M -193M -179M -162M -305M -20.59B -310M -2.15B -845M -10.77B -815M -798M -34.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/10/26 | US$24.42 | +1.96% | 1,245,363 |
| 19/10/26 | US$23.95 | -0.29% | 1,192,873 |
| 16/10/26 | US$24.02 | -6.10% | 1,947,565 |
| 15/10/26 | US$25.58 | -0.16% | 1,734,427 |
| 14/10/26 | US$25.62 | +1.34% | 1,884,113 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions

















